Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Income from Continuing Operations (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Income from Continuing Operations for 16 consecutive years, with 1415422.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 25.67% to 1415422.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2851491.0 through Dec 2025, up 55.77% year-over-year, with the annual reading at 2851491.0 for FY2025, 55.77% up from the prior year.
  • Income from Continuing Operations hit 1415422.0 in Q4 2025 for Cumberland Pharmaceuticals, up from 1949046.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1248184.0 in Q1 2025 to a low of 6301987.0 in Q4 2023.
  • Historically, Income from Continuing Operations has averaged 1343790.05 across 5 years, with a median of 1383549.5 in 2022.
  • Biggest five-year swings in Income from Continuing Operations: crashed 1204.25% in 2024 and later surged 165.61% in 2025.
  • Year by year, Income from Continuing Operations stood at 4387576.0 in 2021, then surged by 43.94% to 2459714.0 in 2022, then tumbled by 156.21% to 6301987.0 in 2023, then soared by 69.78% to 1904306.0 in 2024, then increased by 25.67% to 1415422.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for CPIX at 1415422.0 in Q4 2025, 1949046.0 in Q3 2025, and 735207.0 in Q2 2025.